Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00524823
Status:
UNKNOWN
Last Update Posted:
2007-09-05
First Post:
2007-09-03
Brief Title:
Early Detection of Prostate Cancer by FACS
Sponsor:
Ziv Hospital
Organization:
Ziv Hospital
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2007-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FACS
Brief Summary:
Early detection of prostrate cancer and development of metastases The research will attempt to match the SCM test structuredness of the cytoplasmic matrix in lymphocytes as an early cancer detection test using Florescent Activated Cell Sorting FACS as a replacement for the CellScan instrument The test is based on measurement of cellular changes in response to the specific prostate antigen PSA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None